The estimated Net Worth of Kevin James Sullivan is at least $6.1 Million dollars as of 31 August 2016. Kevin Sullivan owns over 1,000 units of Penumbra Inc stock worth over $5,957,827 and over the last 9 years Kevin sold PEN stock worth over $140,760.
Kevin has made over 2 trades of the Penumbra Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Kevin sold 1,000 units of PEN stock worth $70,380 on 31 August 2016.
The largest trade Kevin's ever made was selling 1,000 units of Penumbra Inc stock on 31 August 2016 worth over $70,380. On average, Kevin trades about 500 units every 0 days since 2016. As of 31 August 2016 Kevin still owns at least 29,449 units of Penumbra Inc stock.
You can see the complete history of Kevin Sullivan stock trades at the bottom of the page.
Kevin's mailing address filed with the SEC is ONE PENUMBRA PLACE, 1351 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502.
Over the last 9 years, insiders at Penumbra Inc have traded over $197,637,326 worth of Penumbra Inc stock and bought 700 units worth $109,480 . The most active insiders traders include Adam Elsesser, Arani Bose, and James Robert Pray. On average, Penumbra Inc executives and independent directors trade stock every 9 days with the average trade being worth of $2,030,383. The most recent stock trade was executed by Harpreet Grewal on 4 September 2024, trading 782 units of PEN stock currently worth $159,614.
penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.
Penumbra Inc executives and other stock owners filed with the SEC include: